secwatch.observer — SEC 8-K summary
======================================

Issuer:     Skye Bioscience, Inc. (SKYE)
CIK:        0001516551
Form:       8-K
Filed at:   2022-11-23T23:59:59+00:00
Accession:  0001516551-22-000052
Event type: debt
Sentiment:  negative
Materiality: 0.70
Item codes: 1.01, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Skye Bioscience prepays $945K debt, extends maturity, reprices warrants to $0.017
--------------------------------------------------------------------------------

- Prepaid $944,862 of principal and interest; remaining convertible debt of $1.848M.
- Maturity of credit agreement extended to December 30, 2022.
- Exercise price of 16.6M Emerald warrants reduced from $0.50/$0.151 to $0.017 per share.
- Company agreed to negotiate registration rights for shares underlying warrants.
- Warrant repricing significantly increases potential future dilution for existing shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/0001516551-22-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1516551/000151655122000052/skye-20221117.htm
  HTML page:      https://secwatch.observer/filing/0001516551-22-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer